HU169437B - - Google Patents

Info

Publication number
HU169437B
HU169437B HUAO372A HUAO000372A HU169437B HU 169437 B HU169437 B HU 169437B HU AO372 A HUAO372 A HU AO372A HU AO000372 A HUAO000372 A HU AO000372A HU 169437 B HU169437 B HU 169437B
Authority
HU
Hungary
Application number
HUAO372A
Other languages
Hungarian (hu)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of HU169437B publication Critical patent/HU169437B/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/1013—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing O or S as heteroatoms, e.g. Cys, Ser
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/665—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • C07K14/695—Corticotropin [ACTH]
    • C07K14/6955—Corticotropin [ACTH] with at least 1 amino acid in D-form
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06104—Dipeptides with the first amino acid being acidic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0812—Tripeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/1008—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/101—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1027—Tetrapeptides containing heteroatoms different from O, S, or N
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
HUAO372A 1972-07-15 1973-07-13 HU169437B (cg-RX-API-DMAC7.html)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NLAANVRAGE7209839,A NL175618C (nl) 1972-07-15 1972-07-15 Werkwijze ter bereiding van een farmaceutisch preparaat met psychofarmacologische werking, dat een peptide of peptide-derivaat bevat, alsmede een werkwijze ter bereiding van dergelijke peptiden.

Publications (1)

Publication Number Publication Date
HU169437B true HU169437B (cg-RX-API-DMAC7.html) 1976-11-28

Family

ID=19816526

Family Applications (1)

Application Number Title Priority Date Filing Date
HUAO372A HU169437B (cg-RX-API-DMAC7.html) 1972-07-15 1973-07-13

Country Status (13)

Country Link
US (1) US3853838A (cg-RX-API-DMAC7.html)
JP (1) JPS5936611B2 (cg-RX-API-DMAC7.html)
AU (1) AU471401B2 (cg-RX-API-DMAC7.html)
BE (1) BE802335A (cg-RX-API-DMAC7.html)
CA (1) CA1019723A (cg-RX-API-DMAC7.html)
CH (1) CH605674A5 (cg-RX-API-DMAC7.html)
DE (1) DE2335826C2 (cg-RX-API-DMAC7.html)
FR (1) FR2192838B1 (cg-RX-API-DMAC7.html)
GB (1) GB1439225A (cg-RX-API-DMAC7.html)
HU (1) HU169437B (cg-RX-API-DMAC7.html)
NL (1) NL175618C (cg-RX-API-DMAC7.html)
SE (1) SE392721B (cg-RX-API-DMAC7.html)
ZA (1) ZA734648B (cg-RX-API-DMAC7.html)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7607683A (nl) * 1976-07-12 1978-01-16 Akzo Nv Werkwijze ter bereiding van nieuwe peptiden en peptide-derivaten en de toepassing hiervan.
US4144228A (en) * 1976-05-07 1979-03-13 G. D. Searle & Co. Methionine5 -enkephalin sulfoxides and sulfones
NL7607684A (nl) * 1976-07-12 1978-01-16 Akzo Nv Werkwijze ter bereiding van nieuwe peptiden en peptide-derivaten en de toepassing hiervan.
US4356119A (en) * 1978-09-28 1982-10-26 Nordisk Insulinlaboratorium Therapeutically active polypeptides or acid addition salts and a process for producing such compounds
US4623715A (en) * 1984-10-22 1986-11-18 Hoechst Aktiengeselleschaft Novel peptides which are active on the central nervous system and have an action on the cholinergic system
NZ214543A (en) * 1984-12-14 1990-03-27 Australian Commercial Research Amino acid and peptide derivatives that inhibit human leucocytic elastase enzyme (hle)
US7592304B2 (en) 1999-10-01 2009-09-22 Dmi Life Sciences, Inc. Metal-binding compounds and uses therefor
US7632803B2 (en) * 1999-10-01 2009-12-15 Dmi Life Sciences, Inc. Metal-binding compounds and uses therefor
RU2315057C2 (ru) * 2006-02-17 2008-01-20 Закрытое акционерное общество "Синтез пептидов" Способ получения аналогов аденокортикотропного гормона (актг), последовательности (4-10), обладающих нейротропной активностью, и тетрапептид для его получения
US20130059914A1 (en) 2010-04-21 2013-03-07 Signature Therapeutics, Inc. Compositions Comprising Enzyme-Cleavable Amphetamine Prodrugs and Inhibitors Thereof
KR20230174213A (ko) 2021-03-09 2023-12-27 엔사이스 바이오사이언시즈 인크. 나파모스타트의 변형된 방출 조성물 및 그의 사용 방법
CN117715632A (zh) 2021-03-09 2024-03-15 恩赛斯生物科学股份有限公司 包含酶可裂解的前药和萘莫司他的组合物及其使用方法
MX2024003466A (es) 2021-09-29 2024-06-04 Ensysce Biosciences Inc Profarmacos de metadona escindibles por enzimas y metodos de uso de los mismos.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL278010A (cg-RX-API-DMAC7.html) * 1961-05-04 1900-01-01
NL6509727A (cg-RX-API-DMAC7.html) * 1965-07-28 1967-01-30
GB1230472A (cg-RX-API-DMAC7.html) * 1967-07-10 1971-05-05

Also Published As

Publication number Publication date
NL175618B (nl) 1984-07-02
FR2192838B1 (cg-RX-API-DMAC7.html) 1977-01-28
CA1019723A (en) 1977-10-25
NL7209839A (cg-RX-API-DMAC7.html) 1974-01-17
US3853838A (en) 1974-12-10
CH605674A5 (cg-RX-API-DMAC7.html) 1978-10-13
DE2335826A1 (de) 1974-01-31
JPS5936611B2 (ja) 1984-09-05
DE2335826C2 (de) 1984-01-05
JPS4951278A (cg-RX-API-DMAC7.html) 1974-05-18
FR2192838A1 (cg-RX-API-DMAC7.html) 1974-02-15
ZA734648B (en) 1974-06-26
SE392721B (sv) 1977-04-18
AU471401B2 (en) 1976-04-29
BE802335A (fr) 1974-01-14
AU5798373A (en) 1975-01-16
NL175618C (nl) 1984-12-03
GB1439225A (en) 1976-06-16

Similar Documents

Publication Publication Date Title
FR2192838B1 (cg-RX-API-DMAC7.html)
FR2201379A1 (cg-RX-API-DMAC7.html)
FR2181803A1 (cg-RX-API-DMAC7.html)
JPS5138632B2 (cg-RX-API-DMAC7.html)
JPS4944413A (cg-RX-API-DMAC7.html)
JPS4938965U (cg-RX-API-DMAC7.html)
JPS4989969A (cg-RX-API-DMAC7.html)
JPS4928943A (cg-RX-API-DMAC7.html)
JPS4919714A (cg-RX-API-DMAC7.html)
JPS4958102U (cg-RX-API-DMAC7.html)
JPS4964296A (cg-RX-API-DMAC7.html)
CS151840B1 (cg-RX-API-DMAC7.html)
JPS48106961U (cg-RX-API-DMAC7.html)
CH1291872A4 (cg-RX-API-DMAC7.html)
CH1117073A4 (cg-RX-API-DMAC7.html)
CH587602A5 (cg-RX-API-DMAC7.html)
CH568530A5 (cg-RX-API-DMAC7.html)
CH576549B5 (cg-RX-API-DMAC7.html)
CH568307A5 (cg-RX-API-DMAC7.html)
CH572925A5 (cg-RX-API-DMAC7.html)
CH566148A5 (cg-RX-API-DMAC7.html)
CH566143A5 (cg-RX-API-DMAC7.html)
BG17922A1 (cg-RX-API-DMAC7.html)
CH566534A5 (cg-RX-API-DMAC7.html)
CH585385A5 (cg-RX-API-DMAC7.html)